These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24499107)

  • 1. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy?
    Dai L; Xia P; Di W
    Cancer Invest; 2014 Mar; 32(3):71-80. PubMed ID: 24499107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives on the role of sphingosine 1-phosphate in cancer.
    Pyne S; Pyne NJ
    Handb Exp Pharmacol; 2013; (216):55-71. PubMed ID: 23563651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate signalling in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
    Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo.
    Roviezzo F; Brancaleone V; De Gruttola L; Vellecco V; Bucci M; D'Agostino B; Cooper D; Sorrentino R; Perretti M; Cirino G
    J Pharmacol Exp Ther; 2011 Jun; 337(3):830-7. PubMed ID: 21421740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting sphingosine-1-phosphate signaling for cancer therapy.
    Xie Z; Liu H; Geng M
    Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase 1 as an anticancer therapeutic target.
    Gao Y; Gao F; Chen K; Tian ML; Zhao DL
    Drug Des Devel Ther; 2015; 9():3239-45. PubMed ID: 26150697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
    Hart PC; Chiyoda T; Liu X; Weigert M; Curtis M; Chiang CY; Loth R; Lastra R; McGregor SM; Locasale JW; Lengyel E; Romero IL
    Mol Cancer Res; 2019 Apr; 17(4):870-881. PubMed ID: 30655321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases.
    Arish M; Husein A; Kashif M; Saleem M; Akhter Y; Rub A
    Drug Discov Today; 2016 Jan; 21(1):133-142. PubMed ID: 26456576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
    Ader I; Malavaud B; Cuvillier O
    Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate signaling in skeletal muscle cells.
    Meacci E; Bini F; Battistini C
    Methods Mol Biol; 2012; 874():155-65. PubMed ID: 22528446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies.
    Arish M; Alaidarous M; Ali R; Akhter Y; Rub A
    J Recept Signal Transduct Res; 2017 Oct; 37(5):437-446. PubMed ID: 28758826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity.
    Tan SJ; Lee LJ; Tzeng CR; Wang CW; Hsu MI; Chen CH
    Reprod Biomed Online; 2014 Nov; 29(5):612-20. PubMed ID: 25246113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate as a therapeutic agent.
    Spiegel S; Kolesnick R
    Leukemia; 2002 Sep; 16(9):1596-602. PubMed ID: 12200669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of sphingosine-1-phosphate (S1P).
    Levkau B
    Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression.
    Murph M; Mills GB
    Expert Rev Mol Med; 2007 Oct; 9(28):1-18. PubMed ID: 17935635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate signaling in the cardiovascular system.
    Peters SL; Alewijnse AE
    Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration.
    Danese S; Furfaro F; Vetrano S
    J Crohns Colitis; 2018 Aug; 12(suppl_2):S678-S686. PubMed ID: 28961752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate, a key mediator of the cytokine network: juxtacrine signaling.
    Xia P; Wadham C
    Cytokine Growth Factor Rev; 2011 Feb; 22(1):45-53. PubMed ID: 21051273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
    Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
    Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.